U.S. flag

An official website of the United States government

Format
Sort by

Send to:

Choose Destination

Search results

Items: 3

1.

Expression data of multiple sclerosis patients receiving subcutaneous Interferon-beta-1a therapy [U133 Plus 2.0]

(Submitter supplied) The purpose of this study was to characterize the transcriptional effects induced by subcutaneous IFN-beta-1a treatment (Rebif, 22 µg or 44 µg three times a week) in patients with relapsing-remitting form of multiple sclerosis (MS). By using Affymetrix DNA microarrays, we obtained genome-wide expression profiles of peripheral blood mononuclear cells from 12 MS patients within the first two years of IFN-beta administration.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL14837
60 Samples
Download data: CEL
Series
Accession:
GSE33464
ID:
200033464
2.

Affymetrix Human Genome U133 Plus 2.0 Array [CDF: XLab gahgu133plus2_2.1.0]

(Submitter supplied) NCBI36/hg18 assembly Protocol: See GPL570 platform for the complete description of HG-U133 Plus 2.0 manufacture protocol
Organism:
Homo sapiens
3 Series
1 Related Platform
110 Samples
Download data: CDF
Platform
Accession:
GPL14837
ID:
100014837
3.

Patient 1, 1 month after start of IFN-beta therapy

Organism:
Homo sapiens
Source name:
Peripheral blood mononuclear cells
Platform:
GPL14837
Series:
GSE33464
Download data: CEL
Sample
Accession:
GSM827808
ID:
300827808
Format
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=GSM827808[Accession]|query=1|qty=2|blobid=MCID_67589206c087e3673255353d|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center